Select a medication above to begin.
Xyosted
testosterone enanthate
Black Box Warnings .
Blood Pressure Increases
only indicated in male pts w/ hypogonadal conditions associated w/ structural or genetic etiologies; may cause incr. BP that may incr. risk of major adverse cardiovascular events, incl. non-fatal MI, non-fatal stroke, and cardiovascular death; greater risk in pts w/ cardiovascular risk factors or established CVD; consider baseline cardiovascular risks and control BP prior to tx start; monitor BP 6wk after tx start, then periodically; weigh tx benefits vs. risks in pts who develop cardiovascular risk factors or CVD while on tx
Adult Dosing .
Dosage forms: INJ (auto-injector): 50 mg, 75 mg, 100 mg
primary hypogonadism, male
- [50-100 mg SC qwk]
- Start: 75 mg SC qwk; Info: adjust dose based on testosterone levels
hypogonadotropic hypogonadism, male
- [50-100 mg SC qwk]
- Start: 75 mg SC qwk; Info: adjust dose based on testosterone levels
transgender hormone therapy, masculinizing (off-label)
- [50-100 mg SC qwk]
- Info: adjust dose based on pt tx goals, clinical response, and testosterone levels; refer to WPATH or Endocrine Society guidelines
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.